Explore the link between obesity, diabetes, and breast cancer risk. Learn how treatments like bariatric surgery and medications can reduce this risk and aid in diabetes...
Diabetes Drug News
Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.
Metformin Insulin SGLT-2 GLP-1 DPP-4 Combo drugs Sulfonylureas TZDs
25 readers recommended
In case you missed them, here are our top stories from October 2023 that cover upcoming therapies, groundbreaking research, and more.
46 readers recommended
Join a study investigating BMF-219, a menin inhibitor that could stimulate healthy beta cell regeneration and potentially slow diabetes progression.
115 readers recommended
Lilly’s SURMOUNT-4 trial shows that Mounjaro (tirzepatide) offers remarkable weight loss in patients with a BMI of over 30. Full SURMOUNT-3 trial results highlighted the...
37 readers recommended
This trial is investigating a new oral medication, INV-202, which is designed to improve regulation in the kidney, liver, and pancreas.
74 readers recommended
Data presented at EASD 2023 reveals orforglipron's potential in type 2 diabetes management. The new oral GLP-1 medication demonstrated significant reductions for A1C and...
50 readers recommended
People with type 1 diabetes face higher kidney risks, yet treatments approved for type 2 aren't FDA approved for them due to clinical trial gaps. The EASD 2023 panel...
47 readers recommended
Survodutide, a GLP-1/glucagon dual receptor agonist, shows promising weight loss results in a clinical trial. The injectable medication, developed by Zealand and...
38 readers recommended
At the 59th European Association for the Study of Diabetes in Germany, an expert panel discussed the tremendous cardiovascular health benefits of limiting body weight...
124 readers recommended
Tirzepatide (sold as Mounjaro) is more effective than semaglutide (Ozempic) for both blood glucose control and weight loss, according to a new analysis.
94 readers recommended
The newest study of once-weekly insulins showed that insulin icodec led to similar reductions in A1C and similar time in range compared to once-daily Tresiba (degludec).
76 readers recommended
The FDA is cautioning people that the diabetes medication Ozempic – commonly prescribed off-label for weight loss – may be linked to a rare but severe side effect.
28 readers recommended
Here are our top stories from September 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings, and more.
96 readers recommended
Early research finds that people with type 1 diabetes who started taking Ozempic (semaglutide) were able to reduce their insulin dose. This research suggests potential...
84 readers recommended
Chronic kidney disease is a serious complication for people with diabetes. Recently approved in the U.S., Jardiance (empagliflozin) has been shown to significantly slow...
49 readers recommended
Join clinical trial NCT05018585 investigating Diamyd's impact on people recently diagnosed with type 1 diabetes. The investigational drug could be a game-changer in...
58 readers recommended
CMS initiates drug price negotiations, targeting diabetes drugs among others. Resulting from the Inflation Reduction Act, it aims for cost cuts by 2026, benefiting...
60 readers recommended
Amazon Pharmacy now auto-applies coupons to insulins and other diabetes supplies. See how you can save money and time.
49 readers recommended
New research reveals that individuals over 40 with type 2 diabetes taking statins may have a reduced risk of kidney disease. The study spans 21 years with 20,000...
40 readers recommended
Novo Nordisk's REDEFINE trials test CagriSema for weight and heart health in adults with type 2 diabetes and/or obesity. Participate and shape diabetes care.